Anti-NMDA receptor encephalitis risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 14: | Line 14: | ||
[[Category:Rheumatology]] | [[Category:Rheumatology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
<ref name="pmid23290630">{{cite journal| author=Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T | display-authors=etal| title=Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. | journal=Lancet Neurol | year= 2013 | volume= 12 | issue= 2 | pages= 157-65 | pmid=23290630 | doi=10.1016/S1474-4422(12)70310-1 | pmc=3563251 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23290630 }} </ref> | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 08:04, 13 May 2023
|
Anti-NMDA receptor encephalitis Microchapters |
|
Differentiating Anti-NMDA receptor encephalitis from Other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Anti-NMDA receptor encephalitis risk factors On the Web |
|
American Roentgen Ray Society Images of Anti-NMDA receptor encephalitis risk factors |
|
Directions to Hospitals Treating Anti-NMDA receptor encephalitis |
|
Risk calculators and risk factors for Anti-NMDA receptor encephalitis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] AE Dheeraj Makkar, M.D.[2]
Overview
Risk Factors
The risk factors include females preponderance, the high incidence of the disease in youngsters, and the increased likelihood of an underlying teratoma among African-Americans. Asian patients had a higher incidence of teratomas.
References
- ↑ Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T; et al. (2013). "Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study". Lancet Neurol. 12 (2): 157–65. doi:10.1016/S1474-4422(12)70310-1. PMC 3563251. PMID 23290630.